ZURICH (Reuters) - Swiss drugmaker Novartis posted a quarterly rise in sales that missed expectations and said it would focus on eking out gradual cost savings to boost margins as it prepares a radical business overhaul. [Category: healthNews] http://feeds.reuters.com/~r/reuters/healthNews/~3/WPdDZ2KdGV4/story01.htm
Read More
No comments:
Post a Comment